{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:41:23Z","timestamp":1774435283617,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.sapharm.2023.08.003","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T08:03:05Z","timestamp":1692345785000},"page":"1543-1550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tracking changes in opioid prescriptions dispensed following the enactment of a prescription drug monitoring program use mandate"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4556-872X","authenticated-orcid":false,"given":"Arveen","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Mott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Gilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2023.08.003_bib2","article-title":"Overdose death rates","author":"Abuse NI on","year":"2022","journal-title":"National Institute on Drug Abuse"},{"key":"10.1016\/j.sapharm.2023.08.003_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107563","article-title":"Evidence for state, community and systems-level prevention strategies to address the opioid crisis","volume":"204","author":"Haegerich","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.sapharm.2023.08.003_bib5","series-title":"Evidence-Based Strategies for Preventing Opioid Overdose: What's Working in the United States","year":"2018"},{"key":"10.1016\/j.sapharm.2023.08.003_bib8","article-title":"CDC clinical practice guideline for prescribing opioids for pain \u2014 United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.sapharm.2023.08.003_bib10","article-title":"Dose of reality: opioid data summary dashboard","year":"2019","journal-title":"Wisconsin Depart Health Serv"},{"key":"10.1016\/j.sapharm.2023.08.003_bib14","unstructured":"Mandated Enrollment and Use of PDMP. Prescription drug monitoring program training and technical assistance center. Mandated Enrollment and Usage. Accessed May 12, 2023. https:\/\/www.pdmpassist.org\/."},{"issue":"10","key":"10.1016\/j.sapharm.2023.08.003_bib16","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","article-title":"Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates","volume":"35","author":"Dowell","year":"2016","journal-title":"Health Aff"},{"issue":"1","key":"10.1016\/j.sapharm.2023.08.003_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1257\/pol.20160094","article-title":"The effect of prescription drug monitoring programs on opioid utilization in medicare","volume":"10","author":"Buchmueller","year":"2018","journal-title":"Am Econ J Econ Pol"},{"key":"10.1016\/j.sapharm.2023.08.003_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.drugalcdep.2018.03.036","article-title":"Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing","volume":"188","author":"Winstanley","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.sapharm.2023.08.003_bib19","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1377\/hlthaff.2017.1321","article-title":"Four states with robust prescription drug monitoring programs reduced opioid dosages","volume":"37","author":"Haffajee","year":"2018","journal-title":"Health Aff"},{"key":"10.1016\/j.sapharm.2023.08.003_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2019.02.010","article-title":"Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing","volume":"199","author":"Strickler","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"10.1016\/j.sapharm.2023.08.003_bib21","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1377\/hlthaff.2019.00103","article-title":"Prescription drug monitoring program mandates: impact on opioid prescribing and related hospital use","volume":"38","author":"Wen","year":"2019","journal-title":"Health Aff"},{"key":"10.1016\/j.sapharm.2023.08.003_bib22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.drugalcdep.2017.05.023","article-title":"Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity","volume":"178","author":"Brown","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.sapharm.2023.08.003_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jpain.2017.11.010","article-title":"The effect of a statewide mandatory prescription drug monitoring program on opioid prescribing by emergency medicine providers across 15 hospitals in a single health system","volume":"19","author":"Suffoletto","year":"2018","journal-title":"J Pain"},{"issue":"10","key":"10.1016\/j.sapharm.2023.08.003_bib24","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1377\/hlthaff.2018.0512","article-title":"Assessing the impact of state policies for prescription drug monitoring programs on high-risk opioid prescriptions","volume":"37","author":"Bao","year":"2018","journal-title":"Health Aff"},{"issue":"8","key":"10.1016\/j.sapharm.2023.08.003_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135957","article-title":"Impact of a mandatory prescription drug monitoring program on prescription of opioid analgesics by dentists","volume":"10","author":"Rasubala","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.sapharm.2023.08.003_bib26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/pds.4766","article-title":"Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City","volume":"28","author":"Bachhuber","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.sapharm.2023.08.003_bib27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/1536867X1501500208","article-title":"Conducting interrupted time-series analysis for single- and multiple-group comparisons","volume":"15","author":"Linden","year":"2015","journal-title":"STATA J"},{"key":"10.1016\/j.sapharm.2023.08.003_bib28","author":"Atkinson"},{"key":"10.1016\/j.sapharm.2023.08.003_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v058.i03","article-title":"Changepoint: an R package for changepoint analysis","volume":"58","author":"Killick","year":"2014","journal-title":"J Stat Software"},{"key":"10.1016\/j.sapharm.2023.08.003_bib30","doi-asserted-by":"crossref","unstructured":"Antibiotic prescribing for common infections in UK general practice: variability and drivers | J Antimicrobial Chemother \u00a6 Oxford Acad. Accessed May 12, 2023. https:\/\/academic.oup.com\/jac\/article\/74\/8\/2440\/5481890.","DOI":"10.1093\/jac\/dkz163"},{"issue":"4","key":"10.1016\/j.sapharm.2023.08.003_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12546-021-09256-2","article-title":"Change point detection for COVID-19 excess deaths in Belgium","volume":"39","author":"Shang","year":"2022","journal-title":"J Popul Res Canberra ACT"},{"issue":"3","key":"10.1016\/j.sapharm.2023.08.003_bib32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/pds.4613","article-title":"Benefits of combining change-point analysis with disproportionality analysis in pharmacovigilance signal detection","volume":"28","author":"Trinh","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.sapharm.2023.08.003_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010709","article-title":"Impact of integrated health system changes, accelerated due to an earthquake, on emergency department attendances and acute admissions: a Bayesian change-point analysis","volume":"6","author":"Schluter","year":"2016","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.sapharm.2023.08.003_bib34","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/amiajnl-2011-000793","article-title":"Application of change point analysis to daily influenza-like illness emergency department visits","volume":"19","author":"Kass-Hout","year":"2012","journal-title":"J Am Med Inform Assoc JAMIA"},{"key":"10.1016\/j.sapharm.2023.08.003_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2021.117287","article-title":"Bayesian change point quantile regression approach to enhance the understanding of shifting phytoplankton-dimethyl sulfide relationships in aquatic ecosystems","volume":"201","author":"Liang","year":"2021","journal-title":"Water Res"},{"key":"10.1016\/j.sapharm.2023.08.003_bib36","author":"Opioid Dispensing"},{"key":"10.1016\/j.sapharm.2023.08.003_bib38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.drugalcdep.2019.03.034","article-title":"Advanced visualizations to interpret prescription drug monitoring program information","volume":"201","author":"Weiner","year":"2019","journal-title":"Drug Alcohol Depend"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123003455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123003455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:30:35Z","timestamp":1761557435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741123003455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1551741123003455"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.08.003","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tracking changes in opioid prescriptions dispensed following the enactment of a prescription drug monitoring program use mandate","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}